MAPT and Alzheimer disease: A further discrepancy, specifically for AD, is that even the most aggressive mouse models of Aβ accumulation and early plaque development (e.g., the 5xFAD mouse) do not develop secondary murine tau tangle formation or substantial neuronal loss, as seen in human AD (80).